HER2 Positive Breast Cancer Treatment Pipeline Landscape 2024: Insight Report Reveals Over 60 Companies Developing Innovative Therapies
25. September 2024 04:09 ET
|
Research and Markets
Dublin, Sept. 25, 2024 (GLOBE NEWSWIRE) -- The "HER2 Positive Breast Cancer - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The report encompasses an in-depth...
New Research Publication Sheds Light on Metastatic HR+/HER2- Breast Cancer Market Dynamics and 2032 Forecast
24. Januar 2024 10:38 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Metastatic HR+/HER2 - Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032" report has been added to ResearchAndMarkets.com's...
HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
24. Januar 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics
14. Dezember 2023 11:03 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...
HER2 Inhibitors Global Market Report 2023: Featuring F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Pfizer Inc., Puma Biotechnology Inc., Boehringer-Ingelheim, Mylan & Biocon
07. April 2023 07:03 ET
|
Research and Markets
Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global her2 inhibitors market is expected...
Trastuzumab Biosimilars Global Market Report 2022: Focus on Product Launches by Major Players Shaping Industry
27. September 2022 04:58 ET
|
Research and Markets
Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...
Global HER2 Inhibitors Market Report (2022 to 2031) - Featuring Novartis, Pfizer and Puma Biotechnology Among Others
01. Juli 2022 06:13 ET
|
Research and Markets
Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "HER2 Inhibitors Global Market Report 2022: By Treatment, By Application, By End-User" report has been added to ResearchAndMarkets.com's offering. This...
The Worldwide Breast Cancer Drug Industry is Expected to Reach $27 Billion by 2026
09. März 2022 06:58 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Drug Market (2021-2026) by Drug Type, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Breast Cancer Drugs Market (2021 to 2030) - Players Include Novartis, AstraZeneca and Celgene Among Others
11. November 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 11, 2021 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
22. Oktober 2021 04:53 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...